UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 8, 2006
NEW BRUNSWICK SCIENTIFIC CO., INC.
----------------------------------
(Exact name of registrant as specified in its charter)
NEW JERSEY 0-6994 22-1630072
---------- ------ ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) ile Number) Identification No.)
P.O. BOX 4005
44 TALMADGE ROAD
EDISON, NEW JERSEY 08818-4005
------------------ ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 287-1200
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On November 8, 2006, New Brunswick Scientific Co., Inc. issued a press release
entitled "New Brunswick Scientific Co., Inc., Reports Third-Quarter and
Nine-Month 2006 Financial Results," a copy of which is furnished with this
Current Report on Form 8-K as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(D) EXHIBITS
Exhibit
Number Description of the Exhibit
----- -----------------------------------------------------------------
99.1 Press release dated November 8, 2006, entitled "New Brunswick
Scientific Co., Inc., Reports Third-Quarter and Nine-Month
2006 Financial Results"
Signatures
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
New Brunswick Scientific Co., Inc.
Date: November 8, 2006 By: /s/ Thomas Bocchino
--------------------
Thomas Bocchino
Vice President, Finance and
Chief Financial Officer